CN102908554B - Traditional Chinese medicine composition for treating squamous blepharitis - Google Patents
Traditional Chinese medicine composition for treating squamous blepharitis Download PDFInfo
- Publication number
- CN102908554B CN102908554B CN201210424038.2A CN201210424038A CN102908554B CN 102908554 B CN102908554 B CN 102908554B CN 201210424038 A CN201210424038 A CN 201210424038A CN 102908554 B CN102908554 B CN 102908554B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- medicine composition
- traditional chinese
- blepharitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 208000010217 blepharitis Diseases 0.000 title claims abstract description 13
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 201000001335 squamous blepharitis Diseases 0.000 title abstract 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 5
- 241001406921 Squamosa Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 208000003251 Pruritus Diseases 0.000 abstract description 7
- 238000001816 cooling Methods 0.000 abstract description 2
- 230000007803 itching Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract 2
- 230000002588 toxic effect Effects 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000282806 Rhinoceros Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 240000003705 Senecio vulgaris Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 230000006870 function Effects 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 208000002474 Tinea Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 210000001508 eye Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 241000150100 Margo Species 0.000 description 4
- 241000101040 Pityriasis Species 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000720 eyelash Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000029091 Refraction disease Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000004430 ametropia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- PHMMATAWQLJFIQ-UHFFFAOYSA-N cyanomercury(1+);oxygen(2-) Chemical compound [O-2].[Hg+]C#N.[Hg+]C#N PHMMATAWQLJFIQ-UHFFFAOYSA-N 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010014801 endophthalmitis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004175 meibomian gland Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating squamous blepharitis. The traditional Chinese medicine composition is characterized by comprising the following raw materials by weight: 8-12 g of groundsel, 6-9 g of honeysuckle stem, 6-10 g of dandelion, 6-9 g of radix saposhnikoviae, 6-9 g of radix sophorae flavescentis, 6-9 g of schizonepeta, 6-10 g of radix rehmanniae, 6-9 g of radix paeoniae alba, 6-10 g of coix seed, 4-6 g of rhinoceros horn, 6-9 g of gypsum, 6-10 g of radix scrophulariae, 6-9 g of dendrobe, 6-10 g of red-rooted salvia root, 4-6 g of safflower, 6-9 g of pericarpium citri reticulatae and 6-8 g of liquorice. The traditional Chinese medicine composition has the benefits of clearing away heat and toxic materials, dispelling wind and arresting itching, cooling blood and nourishing yin, and promoting vital energy to activate blood. The traditional Chinese medicine composition has a good effect, is high in healing rate and has few toxic or side effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition of blepharitis squamosa.
As everyone knows, blepharitis squamosa: be because the secretion of eyelid sebaceous gland and tarsal glands is vigorous, so that seborrhea and low-grade infection occurs.Pathogenic cause: be by various physics, chemical stimulation (wind, dirt, cigarette, heat etc.), the reduction of whole body resistance, malnutrition, do not have enough sleep, ametropia and asthenopia etc., when eye is unhygienic, be all its paathogenic factor in addition, mostly be yeast sample mycete or pityriasis trichophyton mentagrophytes infection.The traditional Chinese medical science claims that blepharitis is also rotten or marginal blepharitis of wind string, and pathological changes is confined to the person of corner of the eyes portion and claims blepharitis angularis.Because taste accumulate due to accumulated temperature heat diseases caused by exogenous pathogenic factor ailment said due to cold or exposure.Main manifestations is: sharp, dry sensation, very itch.Commonly use sulfanilamide spongaion or be coated with to put on the skin with 1:5000 mercuric oxycyanide ointment and stare at edge painting affected part poor effect, often repeatedly.
Summary of the invention
The beneficial effect of Chinese traditional treatment primary disease is, with heat-clearing and toxic substances removing, dispelling wind for relieving itching, removing heat from blood YIN nourishing, promoting flow of QI and blood.
Clinically often according to the determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs of different disease type.
Technical problem to be solved by this invention is in order to overcome technical deficiency, and a kind of good effect, short treating period are provided, and remission rate is high, and cost is low, a kind of Chinese medicine composition for the treatment of blepharitis squamosa having no side effect.
For above-mentioned purpose, treat a Chinese medicine composition for blepharitis squamosa, it is characterized in that being formed by the material medicine of following weight proportion: Herba Senecionis Scandentis 8～12g, Caulis Lonicerae 6～9g, Herba Taraxaci 6～10g, Radix Saposhnikoviae 6～9g, Radix Sophorae Flavescentis 6～9g, Herba Schizonepetae 6～9g, the Radix Rehmanniae 6～10g, the Radix Paeoniae Alba 6～9g, Semen Coicis 6～10g, Cornu rhinocerotis 4～6g, Gypsum Fibrosum 6～9g, Radix Scrophulariae 6～10g, Herba Dendrobii 6～9g, Radix Salviae Miltiorrhizae 6～10g, Flos Carthami 4～6g, Pericarpium Citri Reticulatae 6～9g, Radix Glycyrrhizae 6～8g.
Herba Senecionis Scandentis in the present invention is cold in nature, bitter in the mouth, and function cures mainly: heat-clearing and toxic substances removing, improving eyesight, antipruritic.For conjunctival congestion and swelling pain, skin eczema, furuncle ....The < < detailed outline > > that picks up any lost article from the road: star barrier is removed in improving eyesight.Modern study, has antibacterial action.Caulis Lonicerae sweet in the mouth, cold in nature.Attach to the lung and stomach meridians.Function cures mainly: heat-clearing and toxic substances removing, dispelling wind dredging collateral.For epidemic febrile disease heating, toxic-heat and blood stasis, carbuncle skin infection ....Modern study, has antibacterial, antiinflammation.Herba Taraxaci sweet in the mouth, micro-hardship, cold in nature.Function cures mainly: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.For scrofula, furuncle carbuncle toxin, ophthalmia.< < the southern regions of the Yunnan Province book on Chinese herbal medicine > >: apply all pyogenic infections from tumour or sore, the ruined tinea skin ulcer of scabies; Dispel the wind, all sores disappear.Modern pharmacological research, has resisting pathogenic microbes effect, protects the liver, the function of function of gallbladder promoting, enhancing immunity.Radix Saposhnikoviae acrid in the mouth, sweet, slightly warm in nature.Return bladder, liver, spleen channel.Function cures mainly: expelling pathogenic wind from the body surface, and removing dampness to relieve pain, relieving convulsion is jerked surely.Cure mainly: expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic, antipruritic.Modern study, has effect antibacterial, antiinflammatory.Radix Sophorae Flavescentis heat clearing and damp drying, parasite killing, diuresis.For eczema, eczema, skin pruritus ....Modern study, has the effect of antifungal, antiinflammatory, enhancing immunity.Herba Schizonepetae acrid in the mouth, micro-hardship, property is micro-wet.Function cures mainly: dispel the wind, induce sweat, rash, hemostasis.For headache, eye itching, laryngopharynx swelling and pain, carbuncle.< < detailed outline > >: loose wind heat, refresh oneself, throat, the skin ulcer that disappears is swollen.Control stiffness of the nape, black flower in order, and raw skin ulcer.Radix Rehmanniae sweet in the mouth, hardship, cold in nature.GUIXIN, liver, kidney channel.Function cures mainly: hot removing heat from blood, yin nourishing, promotes the production of body fluid.Thirsty for the xerostomia of hyperactivity of fire caused by deficiency of YIN, have a dizzy spell.The Radix Paeoniae Alba, bitter in the mouth acid, cool in nature.Enter liver, spleen channel.Function cures mainly: nourishing blood to suppress the hyperactive liver, and slow middle pain relieving, yin fluid astringing is received antiperspirant.Modern study, has antiinflammatory, strengthens immune effect.Cornu rhinocerotis sour in the mouth is salty, cold in nature.Function cures mainly: heat clearing away, removing heat from blood, arresting convulsion, removing toxic substances.Join Gypsum Fibrosum; Heat-clearing and toxic substances removing.Radix Scrophulariae sweet in the mouth, hardship, salty, cold nature.Return lung, stomach, kidney channel.Function cures mainly: clearing away heat and cooling blood, eliminating fire and detoxication, YIN nourishing.Pathogenic warmth is joined the army, the pericardium that caves in, and maculae caused by violent heat pathogen, constipation, hectic fever due to YIN-deficiency chronic cough, conjunctival congestion, pharyngalgia, scrofula, diphtheria, carbuncle sore tumefacting virus are hindered in consumption of YIN caused by febrile disease, crimson tongue excessive thirst, Tianjin.Herba Dendrobii is slightly cold; Sweet; Return stomach, kidney channel.Function cures mainly: reinforcing stomach reg fluid, nourishing YIN and clearing away heat.For cloudy impairment of body fluid, lose, xerostomia excessive thirst, lack of appetite is retched, deficiency-heat after being ill, poor vision.Radix Salviae Miltiorrhizae bitter in the mouth, slightly warm in nature.Function cures mainly: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.< < Japan hanako materia medica > >: the sedate of reposing, tonneau GUAN-pulse.Control evacuation of pus pain relieving, granulation promoting is put on flesh; Broken stagnated blood, mends new hemopoietic; Headache, acute conjunctivitis, hot temperature is mad vexed.Promoting blood circulation to restore menstrual flow, scattered silt pain relieving.< < detailed outline > >: invigorate blood circulation, moisturize, pain relieving, loose swollen, stimulate the menstrual flow.Pericarpium Citri Reticulatae is warm in nature, acrid in the mouth, bitter in the mouth.Cure mainly function: regulating qi-flowing for strengthening spleen, in tune, dampness, reduces phlegm.Temperature can circulation of qi promoting, and pungent can dispersing is bitter and sluice.Join Flos Carthami, Radix Salviae Miltiorrhizae promoting flow of QI and blood.Radix Glycyrrhizae, flat.GUIXIN, lung, spleen, stomach warp.Function cures mainly: QI invigorating invigorating middle warmer, relieving spasm to stop pain, nourishing the lung to arrest cough, eliminating fire and detoxication, coordinating the actions of various ingredients in a prescription.< < herbal classic > >: main the five internal organs six mansion cold and heat pathogens, hard muscles and bones, longue meat, times power, incised wound is swollen, removing toxic substances.Above compatibility of drugs, bring out the best in each other.
The present invention follows the prescription principle of the traditional Chinese medical science, the use that is decocted in water for oral dose, and through clinical application for many years checking, total effective rate is 98.36%, and cure rate is 91.8%.Have no side effect.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1: a kind of Chinese medicine composition for the treatment of blepharitis squamosa, is characterized in that being made by the material medicine of following weight proportion: Herba Senecionis Scandentis 8～12g, Caulis Lonicerae 6～9g, Herba Taraxaci 6～10g, Radix Saposhnikoviae 6～9g, Radix Sophorae Flavescentis 6～9g, Herba Schizonepetae 6～9g, the Radix Rehmanniae 6～10g, the Radix Paeoniae Alba 6～9g, Semen Coicis 6～10g, Cornu rhinocerotis 4～6g, Gypsum Fibrosum 6～9g, Radix Scrophulariae 6～10g, Herba Dendrobii 6～9g, Radix Salviae Miltiorrhizae 6～10g, Flos Carthami 4～6g, Pericarpium Citri Reticulatae 6～9g, Radix Glycyrrhizae 6～8g.
Embodiment 2: a kind of Chinese medicine composition for the treatment of blepharitis squamosa, is characterized in that being made by the material medicine of following weight proportion: Herba Senecionis Scandentis 8～10g, Caulis Lonicerae 6～8g, Herba Taraxaci 8～10g, Radix Saposhnikoviae 6～8g, Radix Sophorae Flavescentis 6～8g, Herba Schizonepetae 6～8g, the Radix Rehmanniae 6～9g, the Radix Paeoniae Alba 6～8g, Semen Coicis 6～9g, Cornu rhinocerotis 5～6g, Gypsum Fibrosum 6～8g, Radix Scrophulariae 6～9g, Herba Dendrobii 6～8g, Radix Salviae Miltiorrhizae 6～9g, Flos Carthami 5～6g, Pericarpium Citri Reticulatae 6～8g, Radix Glycyrrhizae 6～8g.
Clinical efficacy is summed up:
One, physical data: we are extensive in clinical practice for many years, treatment 61 routine patients, curative effect is frequently good.Taboo: Flos Carthami menstrual phase women, anemia of pregnant woman are cautious use of.
Two, diagnostic criteria: clinical manifestation: main manifestations eye is sharp, dry sensation, very itch.Sign: margo palpebrae is congested, eyelashes and margo palpebrae surface attachment epithelium squama, margo palpebrae surface can have point-like seborrhea, sebum to combine in eyelashes butt, form yellow wax sample secretions, dry rear incrustation, after squama and crust are removed, the margo palpebrae surface of exposing hyperemia, but without ulcer and pus point, eyelashes easily come off, and can demutation.If inflammation does not heal for a long time, can cause pachyblepharosis posterior lip hydrocarbon is blunt circle, and can not with eyeball close contact, if with conjunctivitis, still can there is puncta swelling and outside flop phenomenon and cause excessive tear.Under being caused by epiphora.Lab testing: visible yeast sample mycete or pityriasis tinea bacterium
Three, method of administration: decoct 20,0m1 1 dose, every dose of the every day of being decocted in water for oral dose, being grown up, early, late sub-service.
Four, curative effect judging standard
Recovery from illness: clinical symptoms disappears completely.
Take a turn for the better: clinical symptoms is improved.
Invalid: clinical symptoms is unchanged or increase the weight of.
Five, therapeutic effect: the present invention is for many years in clinical practice, and recovery from illness 56 examples, account for 91.8%; 4 examples that take a turn for the better, account for 6.56%; Invalid 1 example accounts for 1.64%, and total effective rate is 98.36%, and cure rate is 91.8%.
Six, model case
1, Dong X, man, 42 years old, in December, 2009 was medical.Main suit occurred before 2 weeks that eye is sharp, eye is done, itched, and through village doctor, gave erythromycin eye ointment outside painting 1 week, DeGrain, and gargalesthesia increases the weight of, and occurs squama and crust.Lab testing: visible yeast sample mycete.Patient requires to take 15 doses, Chinese medicine of the present invention, and clinical symptoms disappears completely, after half a year, does not follow up a case by regular visits to and does not recur.
2, clump XX, female, 31 years old, in April, 2010 was medical, and that main suit goes out to lose face is dry, itch with squama 11 days, increases the weight of 3 days, gives antiinflammatory collyrium treatment 3 days in local commune hospital, poor effect, lab testing, is shown in pityriasis tinea bacterium.Patient requires to take 20 doses, Chinese medicine of the present invention, and clinical symptoms disappears completely, follows up a case by regular visits to not recurrence after half a year.
3, Xing XX, man, 27 years old, in April, 2011 was medical.Main suit occur ocular pain, dry, very itch with more than squama first quarter moon, increase the weight of 2 days, in local commune hospital, give antiinflammatory collyrium treatment 3 days, poor effect, lab testing: visible pityriasis tinea bacterium.Patient requires to take 20 doses, Chinese medicine of the present invention, and clinical symptoms disappears completely, and lab testing is normal, follows up a case by regular visits to not recurrence after half a year.
Claims (1)
1. treat a Chinese medicine composition for blepharitis squamosa, it is characterized in that being made by the material medicine of following weight proportion: Herba Senecionis Scandentis 8～12g, Caulis Lonicerae 6～9g, Herba Taraxaci 6～10g, Radix Saposhnikoviae 6～9g, Radix Sophorae Flavescentis 6～9g, Herba Schizonepetae 6～9g, the Radix Rehmanniae 6～10g, the Radix Paeoniae Alba 6～9g, Semen Coicis 6～10g, Cornu rhinocerotis 4～6g, Gypsum Fibrosum 6～9g, Radix Scrophulariae 6～10g, Herba Dendrobii 6～9g, Radix Salviae Miltiorrhizae 6～10g, Flos Carthami 4～6g, Pericarpium Citri Reticulatae 6～9g, Radix Glycyrrhizae 6～8g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210424038.2A CN102908554B (en) | 2012-10-23 | 2012-10-23 | Traditional Chinese medicine composition for treating squamous blepharitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210424038.2A CN102908554B (en) | 2012-10-23 | 2012-10-23 | Traditional Chinese medicine composition for treating squamous blepharitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102908554A CN102908554A (en) | 2013-02-06 |
| CN102908554B true CN102908554B (en) | 2014-04-02 |
Family
ID=47607287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210424038.2A Expired - Fee Related CN102908554B (en) | 2012-10-23 | 2012-10-23 | Traditional Chinese medicine composition for treating squamous blepharitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102908554B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104998149A (en) * | 2015-08-19 | 2015-10-28 | 张强 | Traditional Chinese medicine for treating blepharitis |
| CN105055827A (en) * | 2015-08-21 | 2015-11-18 | 蔡宇平 | Traditional Chinese medicine for treating blepharitis ciliaris |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301358A (en) * | 2008-06-10 | 2008-11-12 | 徐萍儿 | Lotion for treating ulcerative blepharitis |
| CN101474317A (en) * | 2009-02-01 | 2009-07-08 | 卢爱民 | Method for preparing Chinese medicine for treating wind-heat excess type blepharitis |
| CN101757143A (en) * | 2008-11-28 | 2010-06-30 | 吴强 | Traditional Chinese medicine for treating chronic blepharitis |
| CN102366528A (en) * | 2011-09-28 | 2012-03-07 | 邓华伦 | Chinese herbal medicine for treating blepharitis |
-
2012
- 2012-10-23 CN CN201210424038.2A patent/CN102908554B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301358A (en) * | 2008-06-10 | 2008-11-12 | 徐萍儿 | Lotion for treating ulcerative blepharitis |
| CN101757143A (en) * | 2008-11-28 | 2010-06-30 | 吴强 | Traditional Chinese medicine for treating chronic blepharitis |
| CN101474317A (en) * | 2009-02-01 | 2009-07-08 | 卢爱民 | Method for preparing Chinese medicine for treating wind-heat excess type blepharitis |
| CN102366528A (en) * | 2011-09-28 | 2012-03-07 | 邓华伦 | Chinese herbal medicine for treating blepharitis |
Non-Patent Citations (3)
| Title |
|---|
| 张绍民主编.睑缘炎.《家庭医学实用大全》.2002, * |
| 毛泉报等.复方苦参洗剂治疗睑缘炎342例.《河北中医》.2002,第24卷(第11期), * |
| 焦平主编.睑缘炎.《小儿常见病症防治》.1998, * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102908554A (en) | 2013-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103735721B (en) | A kind of Chinese medicine treating pink-eye | |
| CN103610817B (en) | A kind of anus washing liquid | |
| CN103211942B (en) | Chinese medicament for treating acute conjunctivitis | |
| CN102908554B (en) | Traditional Chinese medicine composition for treating squamous blepharitis | |
| CN104784346A (en) | Pruritus treating traditional Chinese medicine lotion preparation method | |
| CN103550479B (en) | A kind of topical composition for the treatment of rheumatalgia | |
| CN103933299A (en) | Chinese herbal preparation for treating rheumatic arthritis | |
| CN104758668A (en) | Traditional Chinese medicine composition for treating tympanites with syndrome of accumulation and binding of water-heat | |
| CN104958735A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN104013913A (en) | Traditional Chinese medicine preparation for treating pharyngalgia otitis media | |
| CN104815029B (en) | A kind of drug and preparation method thereof for treating tinea pedis | |
| CN102973882A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN102631633B (en) | Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis | |
| CN103550620B (en) | A kind of externally-applied medicinal composition treating rheumatalgia | |
| CN103127258A (en) | A kind of traditional Chinese medicine for treating rheumatoid arthritis | |
| CN101564510A (en) | Chinese medicament liniment for effectively treating fungal infection of hand | |
| CN103055158A (en) | Traditional Chinese medicine composition for treating squamous blepharitis | |
| CN105663905A (en) | Traditional Chinese medicinal prescription for treating chronic rhinitis | |
| CN103599498B (en) | Traditional Chinese medicine composition for treating pathogenic wind-heat staying within eyelid type keratoconjunctivitis | |
| CN104997949A (en) | Traditional Chinese medicine for treating rhinitis and preparation method thereof | |
| CN105727132A (en) | Traditional Chinese medicine eye drops for treating eye inflammation and preparation method thereof | |
| CN103977107A (en) | Traditional Chinese medicine composition for treating leucoderma | |
| CN104367896A (en) | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof | |
| CN107441259A (en) | A kind of capsule medicine for treating rhinitis and nasosinusitis and preparation method thereof | |
| CN105998271A (en) | Traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 Termination date: 20141023 |
|
| EXPY | Termination of patent right or utility model |